Drug Information

Drug General Information
Drug ID
D04SPJ
Former ID
DIB001567
Drug Name
AZD7624
Indication Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] Phase 2 [524912]
Company
Astrazeneca
Structure
Download
2D MOL

3D MOL
Target and Pathway
Target(s) Stress kinase p38 Target Info Inhibitor [533111]
References
Ref 524912ClinicalTrials.gov (NCT02238483) A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy. U.S. National Institutes of Health.
Ref 533111Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2015 Mar;24(3):383-92.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.